KATARZYNA IWANICKI: Open Payments
NPI 1760532790 · MOUNT PROSPECT, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$878 in 38 payments from 9 companies in 2025. Trend: 2023 $414 · 2024 $745 · 2025 $878
Food & beverage: $788Education: $90
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 12 | $274 |
| Regeneron Healthcare Solutions, Inc. | 10 | $223 |
| GENZYME CORPORATION | 9 | $140 |
| SANOFI-AVENTIS U.S. LLC | 1 | $90 |
| Optinose US, Inc. | 2 | $47 |
| Lilly USA, LLC | 1 | $30 |
| Medtronic, Inc. | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $23 |
Products named: DUPIXENT, NUCALA, Xhance, ZEPBOUND, PROPEL, XOLAIR, JOURNAVX.
Industry payments across IL — which companies pay providers there.
